Chester County News and Community Website
MyChesCo is regarded for our timely and relevant Chester County business news and marketplace services. Chester County, PA is home to roughly 48,950 companies, according to the U.S. Census Bureau, most of which are small businesses. Nevertheless, here you will discover publically-traded corporations, entrepreneurial startups, large national chains, company headquarters and virtually everything in between. Chester County is the place for business!
The top employers include the Vanguard Group, QVC Network, and Siemens Medical Solutions USA. Moreover, the main business sectors include Agriculture, Manufacturing, Retail Trade, Biotech, and Tourism. This unique combination of industries has allowed Chester County to maintain a booming economy while keeping a rural atmosphere, despite being one of Pennsylvania’s fastest-growing locations for business.
Yet, while the area can boast being home to many large, nationally known and award-winning brands and companies, the area truly thrives because of small business. The typical company is either owner-operated, family-run, or a small mom-and-pop shop. It is for this reason that Chester County’s economy is one of the strongest and most diversified in the state and the nation. Here you will find everything from High Tech to Amish markets.
WEST CHESTER, PA — A. Duie Pyle ranked first among Northeast and Mid-Atlantic regional less-than-truckload carriers in Logistics Management’s 2026 Quest for Quality Awards, extending the West Chester-based transportation company’s …
A. Duie Pyle Extends 37-Year Logistics Award Streak Read More
DOWNINGTOWN, PA — Hankin Group has opened a 67-unit apartment building at River Station in Downingtown, advancing a second phase that will add 160 residences to the 70-acre mixed-use development …
River Station Adds 67 Apartments as Downingtown Expansion Advances Read More
WAYNE, PA — Aclaris Therapeutics Inc. (NASDAQ: ACRS) raised $40.2 million through an at-the-market stock sale after the second quarter, extending its expected cash runway through the end of 2028 …
Aclaris Raises Capital as Drug Pipeline Spending Accelerates Read More
MALVERN, PA — TELA Bio Inc. (NASDAQ: TELA) granted newly hired Chief Executive Officer Heather Getz stock options covering 2.37 million shares and restricted stock units covering another 500,000 shares, …
TELA Bio Grants New CEO Options on 2.37 Million Shares Read More
WASHINGTON, D.C. — The U.S. Small Business Administration launched a $20 million prize competition for small manufacturers that can rapidly expand domestic production in critical supply-chain sectors, offering non-dilutive capital …
SBA Offers $20 Million to Scale Critical U.S. Suppliers Read More
WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) Chief Executive Officer Wes Kaupinen will address investors Wednesday at the Canaccord Genuity 46th Annual Growth Conference as the clinical-stage biotechnology company …
Palvella CEO to Address Investors at Canaccord Conference Read More
MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) reported higher sequential revenue in the second quarter and projected another increase for the current period as orders outpaced shipments across its …
Vishay Revenue Climbs as Orders Point to Further Growth Read More
CHESTERBROOK, PA — Vishay Precision Group, Inc. (NYSE: VPG) reported stronger second-quarter sales and $95.5 million in orders, but unfavorable currency movements and delayed shipments pushed the precision-measurement company to …
VPG Orders Rise as Currency Pressure Pushes Results to Loss Read More MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) introduced a new infrared receiver series designed to support multiple remote-control code frequencies with a single component, potentially reducing board space and …
Vishay Cuts Component Needs With Wide-Band IR Receivers Read More WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) began its rolling U.S. application for QTORIN rapamycin during the second quarter as higher clinical, manufacturing and regulatory spending more than doubled …
Palvella Advances FDA Filing as Drug Spending Lifts Loss Read More